Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia
- PMID: 11150828
- DOI: 10.1159/000047063
Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia
Abstract
We measured the levels of type IV collagen and lipid peroxides in bronchoalveolar lavage fluid (BALF) from infants with respiratory distress syndrome (RDS) to determine the relationship to the development of bronchopulmonary dysplasia (BPD). We analyzed their levels between two groups, RDS infants who developed BPD (n = 8, BPD group) and those who did not (n = 11, RDS group). The levels of the type IV collagen in the BPD group were significantly higher than those in the RDS group at 3 and 7 days of age (p = 0.0024). In the BPD group, persistently increased levels of the type IV collagen were observed during the period up to 14 days of age. There was a positive relationship between the type IV collagen levels and polymorphonuclear leukocyte counts, and thiobarbituric acid-reactive substance levels in BALF. These results suggest that the increased type IV collagen levels in BALF of BPD infants may reflect pulmonary basement membrane damage and the involvement of oxygen metabolites in its process.
Similar articles
-
Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study.Can Respir J. 2017;2017:8074678. doi: 10.1155/2017/8074678. Epub 2017 Apr 11. Can Respir J. 2017. PMID: 28487624 Free PMC article.
-
The development of lung biochemical monitoring can play a key role in the early prediction of bronchopulmonary dysplasia.Acta Paediatr. 2016 May;105(5):535-41. doi: 10.1111/apa.13233. Epub 2015 Dec 14. Acta Paediatr. 2016. PMID: 26439807 Clinical Trial.
-
Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.Am Rev Respir Dis. 1992 Aug;146(2):492-9. doi: 10.1164/ajrccm/146.2.492. Am Rev Respir Dis. 1992. PMID: 1489146
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
[Bronchopulmonary dysplasia].Rev Mal Respir. 1996 Jul;13(3):243-9. Rev Mal Respir. 1996. PMID: 8765916 Review. French.
Cited by
-
The critical role of collagen VI in lung development and chronic lung disease.Matrix Biol Plus. 2021 Feb 20;10:100058. doi: 10.1016/j.mbplus.2021.100058. eCollection 2021 Jun. Matrix Biol Plus. 2021. PMID: 34195595 Free PMC article. Review.
-
The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source.Front Med (Lausanne). 2015 Dec 23;2:91. doi: 10.3389/fmed.2015.00091. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26779482 Free PMC article. Review.
-
Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity.Arch Dis Child Fetal Neonatal Ed. 2002 May;86(3):F193-7. doi: 10.1136/fn.86.3.f193. Arch Dis Child Fetal Neonatal Ed. 2002. PMID: 11978752 Free PMC article. Clinical Trial.
-
SM22α cell-specific HIF stabilization mitigates hyperoxia-induced neonatal lung injury.Am J Physiol Lung Cell Mol Physiol. 2022 Aug 1;323(2):L129-L141. doi: 10.1152/ajplung.00110.2022. Epub 2022 Jun 28. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35762602 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical